Sorafenib/Docetaxel Dose Escalation Trial
The purpose of this study is to: 1.) Evaluate how your body reacts to sorafenib when taken daily (continuously) in combination with docetaxel given every 3 weeks, and to determine the safety of the two drugs together.2.) Measure your blood levels of sorafenib and docetaxel at specific times after taking the medications.
Neoplasms
DRUG: Sorafenib (Nexavar, BAY43-9006)
To determine the safety, maximum tolerated dose and dose-limiting toxicities of oral sorafenib, 6 weeks
To determine if there is a pharmacokinetic interaction between sorafenib and docetaxel when they are administered together, 6 weeks
The purpose of this study is to: 1.) Evaluate how your body reacts to sorafenib when taken daily (continuously) in combination with docetaxel given every 3 weeks, and to determine the safety of the two drugs together.2.) Measure your blood levels of sorafenib and docetaxel at specific times after taking the medications.